1. Home
  2. GHG vs STRO Comparison

GHG vs STRO Comparison

Compare GHG & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

N/A

Current Price

$1.76

Market Cap

205.1M

ML Signal

N/A

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

N/A

Current Price

$9.07

Market Cap

94.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GHG
STRO
Founded
2004
2003
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.1M
94.9M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
GHG
STRO
Price
$1.76
$9.07
Analyst Decision
Hold
Analyst Count
0
7
Target Price
N/A
$19.67
AVG Volume (30 Days)
18.2K
110.8K
Earning Date
12-30-2025
11-06-2025
Dividend Yield
5.68%
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$174,012,060.00
$105,646,000.00
Revenue This Year
$19.02
$62.61
Revenue Next Year
$8.26
N/A
P/E Ratio
$6.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$5.23
52 Week High
$3.25
$21.90

Technical Indicators

Market Signals
Indicator
GHG
STRO
Relative Strength Index (RSI) 39.37 77.00
Support Level $1.66 $9.53
Resistance Level $1.80 $10.10
Average True Range (ATR) 0.08 0.78
MACD 0.00 0.36
Stochastic Oscillator 40.00 89.12

Price Performance

Historical Comparison
GHG
STRO

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: